Late-Breaking Data: Upadacitinib for Vitiligo Achieves Skin Repigmentation Through Week 52
Iltefat Hamzavi, MD, reviews late-breaking data at AAD on upadacitinib as monotherapy.
Iltefat Hamzavi, MD, Reviews Surgical Treatment Advances for Vitiligo
Hamzavi spoke at the 2023 Pigmentary Disorder Exchange Symposium in Chicago.